Regardless of lacking statistical significance, Grail stated the remark of trending enchancment suggests potential for higher outcomes with extra time, so the corporate is extending observe up by as much as a yr. Extra detailed trial outcomes shall be submitted for presentation on the annual assembly of the American Society of Medical Oncology.
The put up Grail’s Galleri Blood Take a look at Falls Brief in Massive Most cancers-Screening Examine, Shares Sink 50% appeared first on MedCity Information.
